In November last year, the House of Representatives Standing Committee on Health, Aged Care and Sport delivered its bipartisan report “The New Frontier: Delivering better health for all Australians” on the approval processes for new drugs and novel medical technologies in Australia.
Australian Health Journal spoke to some of the industry bodies who were part of the Inquiry, for their comments on the process, the report and hopes in the recommendations being implemented.
Professor John Zalcberg OAM Australian Clinical Trials Alliance (ACTA) Board Director & former ACTA Board Chair
Shanny Dyer, Chief Executive Officer, ARCS Australia
Leanne Wells, Chief Executive Officer, Consumers Health Forum of Australia
Liz de Somer, Chief Executive Officer Medicines Australia
Ian Burgess, Chief Executive Officer,
Medical Technology Association of Australia
Watch Season 5, Australian Health Journal Episode S5E1
You Might also like
-
Research finds many practitioners feel underprepared to navigate men’s distress
Movember’s Men in Mind expands nationally to equip mental health professionals with the tools to better connect with men before they reach crisis point. Research conducted by the Men’s Health Research team at Movember has found men account for three in every four suicide deaths in Australia, and more than 50% had sought help in the year before they died.
-
Career advice from an Emergency Physician in Research
Associate Professor Viet Tran, an experienced emergency physician at the Royal Hobart Hospital. He spoke with Australian Health Journal about the crucial role of emergency departments as the frontline of hospitals, providing immediate care, diagnosis, resuscitation, and serving as a safety net for the healthcare system. Prof. Tran highlights the importance of understanding the daily responsibilities and core aspects of a specialty when choosing a medical career.
-
Imperatives for women diagnosed with ovarian cancer
Professor Clare Scott, a pioneering clinician scientist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, also serves as a medical oncologist at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
Her comprehensive training in medical oncology has fuelled her specialisation in gynaecological cancer, combining rigorous research with clinical trials to improve patient outcomes. With over a decade of involvement in ANZGOG, Australia’s foremost gynaecologic cancer research organisation, she is deeply committed to advancing research and saving lives.